Keyphrases
Community-acquired Bacterial Pneumonia
100%
TP-271
100%
Fluorocycline
100%
MIC90
100%
Methicillin-resistant S. Aureus
37%
Haemophilus Influenzae
25%
Resistance Mechanisms
12%
Antibiotics
12%
Neutropenic
12%
Methicillin-resistant Staphylococcus Aureus
12%
Clinical Development
12%
Mycoplasma Pneumoniae (M. pneumoniae)
12%
Drug Resistance
12%
Streptococcus Pneumoniae
12%
S. Pneumoniae
12%
Respiratory Infection
12%
Gram-positive
12%
Fluoroquinolones
12%
Multidrug-resistant Pathogens
12%
Pneumonia Model
12%
Tetracycline
12%
Community-acquired
12%
Streptococcus Pyogenes (S. pyogenes)
12%
Influenza-like Illness
12%
Panton-Valentine Leukocidin
12%
Macrolide Drugs
12%
Specific Resistance
12%
Gram-negative Pathogens
12%
Legionella Pneumophila Pneumonia
12%
Moraxella Catarrhalis
12%
Resistance Phenotypes
12%
Chlamydia Pneumoniae
12%
Immunocompetent Animal
12%
MIC Assay
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bacterial Pneumonia
100%
Infectious Agent
100%
Staphylococcus Aureus
75%
Meticillin
75%
Haemophilus influenzae
50%
Drug Resistance
25%
Respiratory Tract Infection
25%
Streptococcus
25%
Quinolone Derivative
25%
Tetracycline
25%
Influenza
25%
Streptococcus pyogenes
25%
Mycoplasma Pneumonia
25%
Moraxella catarrhalis
25%
Chlamydia Pneumoniae
25%
Methicillin Susceptible Staphylococcus Aureus
25%
Legionella pneumophila
25%
Panton-Valentine Leukocidin
25%
Macrolide
25%
Immunology and Microbiology
Infectious Agent
100%
MIC90
100%
Staphylococcus Aureus
37%
Colony Forming Unit S
25%
Colony-Forming Unit
25%
Pneumococcus
25%
Haemophilus influenzae
25%
Mycoplasma pneumoniae
12%
Minimum Inhibitory Concentration
12%
Drug Resistance
12%
Streptococcus pyogenes
12%
Chlamydia Pneumoniae
12%
Methicillin Susceptible Staphylococcus Aureus
12%
Legionella pneumophila
12%
Moraxella catarrhalis
12%